skip to main content
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma
Material Type:
Article
Add to e-Shelf

Ibrutinib as a treatment of hematologic autoimmune disorders in patients with indolent B‐cell lymphoma

Daniel, Adrien ; Ghez, David ; Ravaiau, Camille ; Cavalieri, Doriane ; Tournilhac, Olivier ; Herbaux, Charles ; Roriz, Mélanie ; Wemeau, Mathieu ; Guillet, Stéphanie ; Bossard, Jean Baptiste ; Hélène, Demarquette ; Kaphan, Eleonore ; Caroline, Regny ; Florence, Lachenal ; Pierache, Adeline ; Michel, Marc ; Godeau, Bertrand ; Terriou, Louis

European journal of haematology, 2022-12, Vol.109 (6), p.719-727 [Peer Reviewed Journal]

England: Wiley Subscription Services, Inc

Full text available

2
Validation of leaf and microbial pectinases: commercial launching of a new platform technology
Material Type:
Article
Add to e-Shelf

Validation of leaf and microbial pectinases: commercial launching of a new platform technology

Daniell, Henry ; Ribeiro, Thuanne ; Lin, Shina ; Saha, Prasenjit ; McMichael, Colleen ; Chowdhary, Rashmi ; Agarwal, Anshika

Plant biotechnology journal, 2019-06, Vol.17 (6), p.1154-1166 [Peer Reviewed Journal]

England: John Wiley & Sons, Inc

Full text available

3
Amphiphilic additives in silicone oil tamponade and emulsification: an eye‐on‐a‐chip study
Material Type:
Article
Add to e-Shelf

Amphiphilic additives in silicone oil tamponade and emulsification: an eye‐on‐a‐chip study

Lu, Yongjie ; Chan, Yau Kei ; Lau, Long Hei ; Wong, David ; Wong, Jasper Ka Wai ; Shih, Kendrick Co ; Lai, Shiu Ming ; Shum, Ho Cheung

Acta ophthalmologica (Oxford, England), 2020-03, Vol.98 (2), p.e232-e237 [Peer Reviewed Journal]

England: Wiley Subscription Services, Inc

Full text available

4
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
Material Type:
Article
Add to e-Shelf

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas

Nakamura, T. ; Tateishi, K. ; Niwa, T. ; Matsushita, Y. ; Tamura, K. ; Kinoshita, M. ; Tanaka, K. ; Fukushima, S. ; Takami, H. ; Arita, H. ; Kubo, A. ; Shuto, T. ; Ohno, M. ; Miyakita, Y. ; Kocialkowski, S. ; Sasayama, T. ; Hashimoto, N. ; Maehara, T. ; Shibui, S. ; Ushijima, T. ; Kawahara, N. ; Narita, Y. ; Ichimura, K.

Neuropathology and applied neurobiology, 2016-04, Vol.42 (3), p.279-290 [Peer Reviewed Journal]

England: Blackwell Publishing Ltd

Full text available

5
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real‐world setting: The ALFA study
Material Type:
Article
Add to e-Shelf

Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real‐world setting: The ALFA study

Roussel, Murielle ; Texier, Nathalie ; Nael, Virginie ; Bitetti, Jacopo ; Paka, Prani ; Kerbouche, Naima ; Sail, Lynda ; Colin, Xavier ; Leleu, Xavier

European journal of haematology, 2024-09, Vol.113 (3), p.310-320 [Peer Reviewed Journal]

England: Wiley Subscription Services, Inc

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far